A new research has revealed that a new combination of powerful drugs could cure kidney cancer tumours. A cocktail of ipilimumab and nivolumab drugs significantly reduced the tumours of 40 percent of patients with terminal kidney cancer while 10 percent were left with ‘no detectable sign of cancer’ reports Sky news.
The drugs block the cancerous tumour’s ability to neutralise key cells in the immune system, giving the body an opportunity to fight off the cancer.
The combination of the two immunotherapy drugs has been approved in treating skin cancer melanoma in the UK but not for Kidney and lung cancer.
The treatment isn’t cheap it costs about £100,000 per patient
“The results from CheckMate -016 are encouraging, and warrant further study, as they show with nearly two years of follow-up, 40.4 per cent of patients in each nivolumab plus ipilimumab combination arm responded to the regimen, with the majority of responses occurring early and within the first few months of treatment.” Dr Hans Hammers, from the University of Texas Southwestern Medical Centre in the US
The findings were presented at the European Society for Medical Oncology cancer meeting in Copenhagen.